Genecure logo — Innovative gene transfer technology aiming to combat genetic...

Genecure

Innovative gene transfer technology aiming to combat genetic disorders, infectious diseases, and cancers since 1998.

Founded 1998 Series Unknown Total: $2.00M Biotechnology, Health Care

General Information

Company Name Genecure
Founded Year 1998
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when Genecure moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Genecure

Genecure is a biotechnology company focused on using its patented gene transfer technology to develop treatments for a range of severe human diseases, including genetic disorders, infectious diseases, and various cancers. The company, established in 1998, is headquartered in Norcross, Georgia. Genecure's slogan, "Innovative gene transfer technology aiming to combat genetic disorders, infectious diseases, and cancers since 1998," reflects its dedication to leveraging innovative biotechnological approaches. The company received a $2.00M Venture Round investment on 21 February 2014, showcasing confidence from investors in its technology and development. This investment underlines the potential seen in Genecure's approach to addressing critical medical needs through advanced genetic solutions. With a focus on biotechnology and healthcare, Genecure positions itself at the intersection of cutting-edge science and potentially impactful medical treatments. As it continues to grow and evolve, this company holds promise in its pursuit of combatting challenging diseases at the genetic level.

Taxonomy: Gene transfer technology, Genetic disorders, Infectious diseases, Cancer treatments, Biotech startups, Innovative therapies, Norcross, Georgia, Emerging biotech company, Life-threatening diseases, Genetic disease treatments, Infectious disease treatments, Cancer research, Medical innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 21 Feb 2014

Genecure Alternatives & Competitors

Genecure vs

Crafting powerful antibody treatments sourced from the immune systems of recovered patients and immu...

Series Unknown
Biotechnology
Genecure vs

Empowering health with advanced solutions against liver disease and comprehensive molecular testing...

46 employees
Biotechnology, Health Care
Genecure vs

Leading the Fight Against Cancer, Infections, and Immune Disorders with Innovative Treatments

Series Unknown
Biopharma, Biotechnology

FAQ About Genecure

Innovative gene transfer technology aiming to combat genetic disorders, infectious diseases, and cancers since 1998.
Genecure was founded in 1998.
Genecure operates in the following industries: Biotechnology, Health Care.
Genecure has completed 1 funding round, raising a total of $2.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Genecure include AIMM Therapeutics, 福建广生堂药业股份有限公司, Iyuda Therapeutics, Transformative Biotech, LLC, EOM Pharmaceuticals . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genecure and AIMM Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Genecure and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy